Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 10, 2017

Primary Completion Date

June 7, 2019

Study Completion Date

August 5, 2019

Conditions
Breast Cancer
Interventions
DRUG

Indocyanine Green

"Subcutaneous injection (1 ml) of the indocyanine green into the ipsilateral upper extremity 10 min before the surgery.~Near Infra-red images acquisition is performed during surgery"

Trial Locations (1)

94805

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT02994225 - Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity | Biotech Hunter | Biotech Hunter